Tackling immunosenescence to improve COVID-19 outcomes and vaccine response in older adults. (2020)
Attributed to:
GEroscience and Multi-Morbidity: identifying targets for intervention (GEMM)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2666-7568(20)30011-8
PubMed Identifier: 33521768
Publication URI: http://europepmc.org/abstract/MED/33521768
Type: Journal Article/Review
Volume: 1
Parent Publication: The Lancet. Healthy longevity
Issue: 2
ISSN: 2666-7568